S. Drover et al., ANALYSIS OF MONOCLONAL-ANTIBODIES SPECIFIC FOR UNIQUE AND SHARED DETERMINANTS ON HLA-DR4 MOLECULES, Human immunology, 40(1), 1994, pp. 51-60
The specificities for seven mAbs to HLA-DR4 were determined initially
using homozygous BCLs and L-cell transfectants expressing wild-type DR
molecules. Three antibodies (NFLD.D1, NFLD.M1, and NFLD.D7) bound all
DR4 molecules, but only one was specific for DR4. Four antibodies (NF
LD.D2, NFLD.D3, NFLD.D8, and NFLD.D10) reacted with some but not all D
R4 subtypes and had extra reactions, particularly with DR gene product
s associated with susceptibility to RA. To localize the antibody-bindi
ng epitopes on DR4 molecules, the antibodies were then analyzed on tra
nsfectants expressing hybrid genes, which were generated by exon shuff
ling of DRB10403 and DRB1*0701. Two of the pan-DR4 antibodies bound e
pitopes that require the beta(2), domain while the third mapped primar
ily to the HVR-I region. One antibody NFLD.D10 to subtypes of DR4 mapp
ed to residues 40-97 on DR beta 10403 chains. Comparison of reaction
patterns with amino acid sequences suggest that the antibodies against
subtypes of DR4 are specific primarily for a region containing sequen
ces postulated to determine susceptibility to RA.